Synapse

← CHEST Pulmonary

Papers in CHEST Pulmonary

Page 3 · newest first

  1. Caring for Rural Patients With Interstitial Lung DiseaseCHEST Pulmonary · 2025
  2. Trajectories of Health-Related Quality of Life in Patients With Idiopathic Pulmonary FibrosisCHEST Pulmonary · 2024
  3. Epidemiology and Clinical Outcomes of Cardiac Arrhythmias in Pulmonary Arterial HypertensionCHEST Pulmonary · 2024
  4. Validation of a High-Specificity Blood Autoantibody Test to Detect Lung Cancer in Pulmonary NodulesCHEST Pulmonary · 2024
  5. Spot OnCHEST Pulmonary · 2024
  6. Association of Oxygen Saturation on Home Pulse Oximetry With Telephone Triage DecisionCHEST Pulmonary · 2024
  7. Delays in Referral to Multidisciplinary Care for Black Individuals With SarcoidosisCHEST Pulmonary · 2024
  8. Practice Patterns of Pulse Dose Corticosteroid Use for Patients Hospitalized With Acute Exacerbations of Idiopathic Pulmonary Fibrosis in the United StatesCHEST Pulmonary · 2024
  9. Impact of Effect Modification of Type 2 Inflammation and Sex on Asthma Exacerbation RatesCHEST Pulmonary · 2024
  10. Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisCHEST Pulmonary · 2024
  11. Remote Patient Monitoring for Managing Interstitial Lung DiseaseCHEST Pulmonary · 2024
  12. An Unusual Case of Giant Bullous DiseaseCHEST Pulmonary · 2024
  13. Feasibility of Assessing the Abnormal Pediatric Airway Using Rotational Optical Coherence TomographyCHEST Pulmonary · 2024
  14. Flow Profiles Identify Sources of Poor Metered Dose Inhaler TechniqueCHEST Pulmonary · 2024
  15. Bronchoscopic Lung Volume ReductionCHEST Pulmonary · 2024
  16. Treatment With Bilevel PAP Is Associated With a Reduction in Severe Exacerbations in COPD-OSA OverlapCHEST Pulmonary · 2024
  17. Quantifying Normal Diaphragmatic Motion and Shape and Their Developmental Changes via Dynamic MRICHEST Pulmonary · 2024
  18. High BMI and COPD Outcomes in Alpha-1 Antitrypsin DeficiencyCHEST Pulmonary · 2024
  19. Chest Wall Deformities in Adults With Fibrotic Interstitial Lung Disease Related to Surfactant-Related Gene MutationsCHEST Pulmonary · 2024
  20. Outcomes and Clinical Practices in Follow-Up of Nonmalignant Pulmonary Nodules After Bronchoscopic BiopsyCHEST Pulmonary · 2024
  21. Racialized economic segregation and disparities in non-small cell lung cancer care and outcomesCHEST Pulmonary · 2024
  22. Use of Ketamine for Conscious Sedation in Flexible BronchoscopyCHEST Pulmonary · 2024
  23. Evolution of Home Mechanical Ventilation in Sweden Over 27 YearsCHEST Pulmonary · 2024
  24. Prospective REALITI-A StudyCHEST Pulmonary · 2024
  25. Sleep Parameters of Breathing and Cognitive Function in a Diverse Hispanic/Latino CohortCHEST Pulmonary · 2024
  26. Safety, Efficacy, and Feasibility of Nebulized Long-Acting Bronchodilators vs Short-Acting Bronchodilators in Hospitalized Patients With Acute Exacerbations of COPDCHEST Pulmonary · 2024
  27. Managing Silicosis in the United StatesCHEST Pulmonary · 2024
  28. Long-Term Clinical Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in People With Cystic Fibrosis and Preexisting Advanced Lung Disease at Treatment InitiationCHEST Pulmonary · 2024
  29. Feasibility and Pathologic Outcomes of Peripheral Lung Vascular Targeted Photodynamic Therapy in a Normal Porcine Lung ModelCHEST Pulmonary · 2024
  30. Health State Utilities Associated With Treatment Burden in Cystic FibrosisCHEST Pulmonary · 2024
  31. A Collaborative, Interinstitutional Program to Improve the Care of Patients With Chronic Thromboembolic Pulmonary HypertensionCHEST Pulmonary · 2024
  32. Potential Clinical Impact of Revised Pulmonary Hypertension Definitions at Moderate AltitudeCHEST Pulmonary · 2024
  33. Pleural Procedure Education in Fellowship A National Survey of Program DirectorsCHEST Pulmonary · 2024
  34. Looking to Philadelphia for Trends in Lung Cancer Risk and Screening Adherence Among Asian AmericansCHEST Pulmonary · 2024
  35. Lung Volume Changes in Stable Preterm Infants Weaned From Nasal CPAP to High FlowCHEST Pulmonary · 2024
  36. The Value of a High-Volume Bronchoscopic Lung Volume Reduction Program for Patients With Severe EmphysemaCHEST Pulmonary · 2024
  37. Sleep Hypoxemia as a Predictor of Mortality in Patients with Sleep ApneaCHEST Pulmonary · 2024
  38. Demographic and Clinical Factors Associated With Diagnostic Confidence in Interstitial Lung DiseaseCHEST Pulmonary · 2024
  39. Critical Analysis of Hemodynamic Risk AssessmentCHEST Pulmonary · 2024
  40. Interventions to Improve Quality of Life and Knowledge in Hypersensitivity PneumonitisCHEST Pulmonary · 2024
  41. Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient RegistryCHEST Pulmonary · 2024
  42. Bronchoscopy Without Sedation in Healthy VolunteersCHEST Pulmonary · 2024
  43. A Two-Way Audio-Visual Teleconferenced Pulmonary Rehabilitation Program Is Safe, Feasible, and Expands Geographic CatchmentCHEST Pulmonary · 2024
  44. Pathogenic Mutations Conferring α1-Antitrypsin Deficiency Are Identified Accurately by a Novel Multiplexed Molecular AssayCHEST Pulmonary · 2024
  45. A 53-Year-Old Woman With Stage IV Non-Small Cell Lung Cancer and Progressive Paratracheal LymphadenopathyCHEST Pulmonary · 2024
  46. Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic FibrosisCHEST Pulmonary · 2024
  47. Machines Are Learning Chest Auscultation. Will They Also Become Our Teachers?CHEST Pulmonary · 2024
  48. COUNTERPOINT: Liquid Markers for Risk Stratification of Pulmonary Nodules, Ready for Prime Time? Not Yet!CHEST Pulmonary · 2024
  49. POINT: Liquid Markers for Risk Stratification of Pulmonary Nodules, Ready for Prime Time? Yes!CHEST Pulmonary · 2024
  50. Rebuttal From Dr Kim et alCHEST Pulmonary · 2024